We observed that short-term incubation of AML cells with venetoclax inhibited Mcl-1 and Bcl-xL protein in control but not in AMPK KO cells, suggesting that this inhibition required AMPK in AML. This evidence concerns the gene PRKAA1 and acute myeloid leukemia.